New IRBM contribution to The Medicine Maker

Our Chief Scientific Officer, Carlo Toniatti, has been featured in The Medicine Maker, where he explored how we can catalyse the discovery and development of oncology drugs.

In the article, he discusses how to overcome the challenges in developing efficacious cancer therapeutics through consultative collaboration between academia and industry. Moreover, he talks about the current reproducibility crisis impacting the entire biosciences ecosystem, calling for a cultural shift in how success is perceived in research and development.

Read the article in full here: https://themedicinemaker.com/discovery-development/putting-patients-first